Pimm – Partial immortalization

A Biotech Geek (micro)Blogger’s adventures through science, technology and the web…

  • email me

    [attilacsordas][at][gmail.com]
  • Attila on Twitter

  • Recent Comments

    revathi on Human mitochondrial DNA vs. nu…
    Erik Cole on Michael Rose, evolutionary SEN…
    drugrehabusa on Stem Cell Therapy Market, US, …
    Letago on Can you tell a good article fr…
    Online Offers on Life extension people are happ…
    เสื้อผ้า on How to read PDF files on iPhon…
    atsoft on Add stem cells and eat the lab…
    Buy SciPhone i68 3G … on Science on the iPhone, is it a…
    Unlock Wii on Whatbox, Upper Lost Side, Stem…
    nobitfashion on LavaAmp: cheapest pocket PCR t…
  • licence

    Creative Commons License
  • c

  •  

    February 2007
    M T W T F S S
    « Jan   Mar »
     1234
    567891011
    12131415161718
    19202122232425
    262728  

Archive for February 15th, 2007

Disruptor candidate stem cell therapies

Posted by attilachordash on February 15, 2007

disruptorstem cellqStem cell therapies are likely to be disruptive treatments for the following medical sectors according to the Stem Cell Market Analysis Fact Sheet:

What is interesting in the following list: all the target tissues are of mesodermal origin.

Total knee implants: Stem cell therapies that repair worn articular or meniscus cartilage will delay and potentially reduce the need for total knee replacement surgery

Sports medicine: Stem cell therapies will extend the continuum of care for “weekend warriors.” It is highly likely that stem cell therapies will become the standard of care for torn meniscus or damaged articular cartilage

Heart muscle repair following heart attacks

Vascularization: To improve flow of blood by stimulating growth of new capillaries and vessels to the heart muscle

• Use of bone marrow transplants: stem cell therapies significantly reduce the effects of graft vs. host disease in patients with transplants.

• Treating the broad range of inflammation in the human body.

Posted in biotechnology, business, industry, regenerative medicine, stem cells, therapy, tissue engineering | Leave a Comment »